23andMe founder Anne Wojcicki will regain control of embattled DNA company after all

In a surprise twist, 23andMe founder and former CEO Anne Wojcicki is set to regain control of the DNA company's assets, according to a press release from 23andMe. In May, a company called Regeneron bought 23andMe for $256 million in a bankruptcy auction, but Wojcicki's nonprofit, TTAM Research Institute, was able to reopen bidding with an "unsolicited offer" of $305 million, The Wall Street Journal reports.

A bankruptcy judge agreed to reopen bidding on 23andMe under the condition that Regeneron top Wojcicki's proposed price by at least $10 million, according to WSJ. Regeneron declined, leaving 23andMe in TTAM's control assuming the judge approves the deal. A hearing to consider the new deal is set for June 17, 2025.

Regeneron had previously planned to keep on all of the company's employees and continue offering consumer DNA testing kits. Besides answering customers' questions about their ...